Alzheimer; News from the web:
There are roughly 326 active, recruiting or enrolling by invitation clinical trials on the elusive disease, per clinicaltrial.gov. The U.S. last year dramatically stepped up funding for Alzheimer’s disease research, from $400 million a year to over $2 billion annually, although the Alzheimer’s Association says more is needed.
The biggest problem: Scientists still don’t know the cause of Alzheimer’s.
Read all about it HERE
Alzheimer; News from the web:
Here is a new drug that seemed effective for mice and now has been found safe for humans, so the next step it to test it on patients with Alzheimer’s. Exciting times
Read all about it HERE
Alzheimer; News from the web:
The companies developing aducanumab, Biogen and its partner Eisai, announced that they halted two late-stage trials of the experimental drug after an independent group’s analysis showed that the trials were unlikely to “meet their primary endpoint.”
The Cambridge, Massachusetts-based biotech giant joins a long list of companies in the last decade that have failed to find a treatment for Alzheimer’s.
Read all about it HERE
Alzheimer; News from the web:
Check out the project in the link for today. The claim is a novel process to find a way to immunize against Alzheimer’s disease. Not sure how this low budget will win from all the billions already spent by the large pharmaceutical companies but see for yourself.
Read all about it HERE
Alzheimer; News from the web:
Yes now we are at the stage that doctors are seriously think they may have found a way to prevent Alzheimer’s to happen. In May, doctors in New York will start testing a novel gene therapy
Read all about it HERE
Alzheimer; News from the web:
A new drug shows promising results: Early results indicate that the drug could reverse natural, age-related cognitive decline. Researchers also believe that it might help patients whose memories are impaired because of conditions such as depression, schizophrenia and Alzheimer’s disease.
Read all about it HERE